https://clinicaltrials.gov/ct2/show/NCT04042025?type=Intr&cond=Spinal+Muscular+Atrophy&lupd_s=06%2F24%2F2020&lupd_d=14&sort=nwst
STUDY TITLE:
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
DESCRIPTION:
Conditions: Spinal Muscular Atrophy Type I; Spinal Muscular Atrophy Type II; Spinal Muscular Atrophy Type III
Intervention: Biological: Onasemnogene Abeparvovec-xioi
Sponsor: AveXis, Inc.
Enrolling by invitation
CLINICALTRIALS.GOV IDENTIFIER:
NCT04042025
FIRST POSTED:
Thu, 01 Aug 2019 12:00:00 EDT
LAST UPDATE POSTED:
07/08/20 07:39AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT04042025?type=Intr&cond=Spinal+Muscular+Atrophy&lupd_s=06%2F24%2F2020&lupd_d=14&sort=nwst